Guest guest Posted January 4, 2007 Report Share Posted January 4, 2007 i remember reading about this medication a while back when i was researching links between MS and CFS. i am now even more interested in this now that they are reporting that one of the modes of action for Aimspro is to modulate the HPA axis that i never knew was also dysfunctional in MS. Aimspro® Aimspro shows great promise for the treatment of a range of neurological and inflammatory conditions including multiple sclerosis, CIDP and rheumatoid arthritis. Aimspro has been characterised biochemically and its mode of action has been determined. It comprises of a set of peptides that act to stimulate the release and regulation in the patient, of a molecular cascade that modulates the Hypothalamo- Pituitary-Adrenal (HPA) axis; a system found to be dysfunctional in some patients suffering from Multiple Sclerosis. In addition, Aimspro has powerful anti-inflammatory properties as it contains cytokines that induce a predominantly TH-2 anti-inflammatory profile in the patient thus relieving symptoms in a wide range of inflammatory conditions. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.